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Since the beginning of the COVID-19 pandemic, access to medical care was restricted for 50 
nearly all non-acute medical conditions. Due to their status as a vulnerable social group and 51 
the inherent need for transition-related treatments (e.g., hormone treatment), transgender 52 
people are assumed to be affected particularly severely by the restrictions caused by the 53 
COVID-19 pandemic. This study aims to assess the impact of the COVID-19 pandemic on the 54 
health and health care of transgender people. 55 
Methods and findings 56 
As an ad hoc collaboration between researchers, clinicians, and 23 community organizations, 57 
we developed a web-based survey. The survey was translated into 26 languages, and 58 
participants were recruited via various social media and LGBTIQ-community sources. 59 
Recruitment started in May 2020. We assessed demographical data, physical and mental 60 
health problems (e.g., chronic physical conditions), risk factors (e.g., smoking), COVID-19 61 
data (symptoms, contact history, knowledge and concerns about COVID-19), and the 62 
influence of the COVID-19 pandemic on access to transgender health care and health-related 63 
supplies. To identify factors associated with the experience of restrictions to transgender 64 
health care, we conducted multivariate logistic regression analysis.  65 
5267 transgender people from 63 higher-middle income and high-income countries 66 
participated in the study. Over 50% of the participants had risk factors for a severe course of 67 
a COVID-19 infection and were at a high risk of avoiding testing or treatment of a COVID-19 68 
infection due to the fear of mistreatment or discrimination. Access to transgender health 69 
care services was restricted due to the COVID-19 pandemic for 50% of the participants. Male 70 
sex assigned at birth and a lower monthly income were significant predictors for the 71 
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experience of restrictions to health care. 35.0% of the participants reported at least one 72 
mental health conditions. Every third participant had suicidal thoughts, and 3.2% have 73 
attempted suicide since the beginning of the COVID-19 pandemic. A limitation of the study is 74 
that we did not analyze data from low-income countries and access to the internet was 75 
necessary to participate. 76 
Conclusions 77 
Transgender people are assumed to suffer under the severity of the pandemic even more 78 
than the general population due to the intersections between their status as a vulnerable 79 
social group, their high amount of medical risk factors, and their need for ongoing medical 80 
treatment. The COVID-19 pandemic can potentiate these vulnerabilities, add new challenges 81 
for transgender individuals, and, therefore, can lead to devastating consequences, like 82 
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Transgender people experience their gender as incongruent with the sex assigned at birth. 100 
They might identify as a binary gender (female, male) or outside of the gender binary. 101 
People who are non-binary might experience their gender as moving between male and 102 
female (e.g., genderfluid) or as situated beyond the gender binary (e.g., genderqueer). Some 103 
reject the concept of sex and gender at all, either on a personal, or a general level (e.g., 104 
agender). Transgender health care primarily focusses on medical measures to support the 105 
person’s transition to live their gender both physically and socially. This may include 106 
hormone therapy, gender-affirming surgery, and a variety of additional interventions (e.g., 107 
voice and communication therapy, hair removal)[1]. For treatment-seeking transgender 108 
people these interventions positively affect mental health and quality of life, and are thus 109 
considered state-of-the-art treatments [2-5]. However, not all transgender people want to 110 
undergo any of these types of care, or might have access to it [6, 7]. 111 
Up to now, transgender people have been considered to be a vulnerable social group, many 112 
of whom have experienced discrimination and marginalization by society, and health care 113 
systems in particular [4, 8]. Access to transgender health care is often restricted due to legal 114 
requirements, financial barriers, and ‘gatekeeping’ health care providers in countries all over 115 
the world [9, 10]. These elements can lead to a negative impact on transgender individual’s 116 
health and quality of life [4].  117 
During to the COVID-19 pandemic access to medical care was, and in some areas globally still 118 
is, restricted for nearly all non-acute medical conditions. State health care, as well as private 119 
practice, were mainly focusing on COVID-19. Since transgender individuals often need access 120 
to medical treatments such as hormone therapy [1], these restrictions are likely to have 121 
increased psychological distress. Due to both their status as a vulnerable social group and 122 
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their need for transition-related treatments [4, 8], this impact may be particularly severe for 123 
transgender people [11]. 124 
Even though some authors have already addressed the impact of the COVID-19 pandemic on 125 
transgender people, there remains a dearth of evidence. Perez-Brumer and Silva-Santisteban 126 
[12] discussed the disparities transgender people face in Peru due to binary-based policies as 127 
a response to the COVID-19 pandemic (only women or men are allowed to leave their homes 128 
on certain weekdays) and how this increasing discrimination impacts physical and mental 129 
health. Van der Miesen and colleagues [13] summarized the intersections between health 130 
care, human rights, and socioeconomic stress for transgender individuals during the COVID-131 
19 pandemic. They state the need for a joint strategy of policy makers, transgender 132 
advocates, health care providers, and governments. Wang and colleagues [11] refer to the 133 
barriers of care for transgender people in times of COVID-19 in light of evidence from their 134 
clinic in Beijing, China. The restricted access to hormone treatment was associated with high 135 
levels of depression and anxiety due to the challenge of continuing presenting and socially 136 
living as their sex assigned at birth. All the authors state the need for collaborative strategies 137 
between relevant stakeholders (e.g., governments, health care providers, advocacy groups) 138 
to actively consider the difficulties faced by the transgender population during the COVID-19 139 
pandemic and the need for high-quality evidence to base strategies upon [11-13]. 140 
Therefore, as the first of its kind, the current study systematically investigates the impact of 141 
the COVID-19 pandemic on the health and health care of transgender individuals. As an ad 142 
hoc collaboration between researchers, community members and clinicians from several 143 
countries, it aims to generate empirical evidence on the situation of transgender individuals 144 
in times of COVID-19 and, therefore, help to develop and implement measures addressing 145 
the obstacles that affect transgender individuals during the pandemic. 146 
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Study design  149 
The TransCareCovid-19 survey (www.transcarecovid-19.com), is a web-based survey 150 
designed to investigate the effects of the COVID-19 pandemic on health care for transgender 151 
individuals. This cross-sectional study was developed by XX, YY, and ZZ in cooperation with 152 
local health care providers and community members. Several members of the research 153 
group are transgender. Additional consultation was sought in the construction of the survey 154 
by peer and professional organisations.  155 
The survey was first developed in German and, in cooperation with 23 community 156 
organisations (for details see www.transcarecovid-19.com), translated into 27 languages 157 
(Arabic, Azerbaijani, Armenian, Bulgarian, Chinese, Croatian, Dutch, English, Farsi, French, 158 
Georgian, German, Hungarian, Italian, Kazakh, Kyrgyz, Macedonian, Polish, Portuguese, 159 
Romanian, Russian, Serbian, Spanish, Swedish, Tajik, Turkish, Ukrainian).  160 
The study followed strict ethical guidelines and received ethical approval from both the Local 161 
Psychological Ethics Committee at the University Medical Center MM-NN (No.: LPEK-0130, 162 
date: 01/04/2020), as well as from PP University Hospital (BC-07607, date: 15/04/2020). All 163 
respondents provided informed consent. 164 
Participants 165 
To recognize the heterogeneity of the transgender population, the survey was open to 166 
anyone who identifies, experiences, and/or describes themselves, as transgender and were 167 
at least 16 years of age. Participants were recruited via postings on LGBTIQ-related social 168 
media channels, mailing lists of support groups and LGBTIQ-related associations, and 169 
through snowball sampling.  170 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint 





Data collection 171 
The data collection started in May 2020 and is still ongoing. The participant recruitment was 172 
supported by several scientific and community organisation (for details see 173 
www.transcarecovid-19.com). The present sample is based on the data collected until 174 
August 9, 2020. We choose this date as the COVID-19 pandemic was slowing down in most 175 
countries all over the world and our data allowed us to give a comprehensive overview on 176 
how the first wave of COVID-19 affected transgender people. This paper consists of analyses 177 
of data from high-income and upper middle-income economies according to the World Bank 178 
country classification[14] only, as participant recruitment for lower middle-income and low-179 
income economies started later.  180 
Variables 181 
The TransCareCovid-19 survey collects demographical data regarding age, education, 182 
occupational status, country of residence, place of residence, residence status, living 183 
situation, financial income, relationship, minority status (person of colour, religious minority, 184 
sexual minority, gender minority, minority due to disability status, another minority), sex 185 
assigned at birth, and gender. The participants’ country of residence was classified by the 186 
current World Bank country classification by income level [14]. Upper middle-income 187 
economies are defined as having a gross national income (GNI) per capita of $4,046 – 188 
$12,535. A country with a GNI per capita of greater than $12,535 is considered a high-189 
income economy. Physical health problems were assessed using items based on established 190 
studies[15, 16] and free-text responses. COVID-19 symptoms, contact history, satisfaction 191 
with information, knowledge, and concerns about COVID-19, were assessed following Wang 192 
and colleagues using 4-point Likert scales (1-highest value, 4-lowest value) [17]. We added 193 
additional items related to transgender-specific discrimination and avoidance of health care 194 
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based on former studies [16]. Finally, data regarding transition-related health care such as 195 
medical procedures which the respondent has undergone, and the influence of the COVID-196 
19 pandemic on access to transgender health care and health-related supplies (e.g., chest 197 
binders), were assessed based on an established protocol [18]. Depending on the procedures 198 
which the respondent had undergone, participants were specifically asked about the 199 
influence of the COVID-19 pandemic on single treatments. For example, only participants 200 
who already used hormones where asked if access to their medication was restricted. Fears 201 
about future restrictions on treatment were investigated if participants had already sought 202 
or planned the treatment. 203 
Due to the method of participant recruitment, access to a web-enabled device, social media 204 
activity, and technical affinity need to be considered as potential biases. By encouraging 205 
participants to promote the survey with their peers we tried to address the issue of lacking 206 
social media activity. Unfortunately, we were not able to provide a paper-pencil version of 207 
the survey due to the wide range of the study and a lack of financial and human resources.  208 
Statistical analysis 209 
Continuous data are presented as mean (SD). Categorical data are presented as n (%). 210 
Missing data were deleted pairwise. To identify factors associated with the experience of 211 
restrictions to transgender health care, we conducted a multivariate logistic regression 212 
analysis. Experiencing restrictions in at least one domain (hormone treatment, hair removal 213 
treatment, surgery, surgical aftercare) was included as depended variable (yes, no). We 214 
entered the covariates in two blocks. Block 1 included age, education (no formal education, 215 
primary, secondary, tertiary education), relationship (yes, no), minority status (person of 216 
colour, religious minority, sexual minority, gender minority), disability (yes, no), sex assigned 217 
at birth (female, male), and gender (binary, non-binary). This block was labelled 218 
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Demographic Characteristics. Block 2 included the following aspects of the social 219 
environment: Countries’ GNI per capita (upper middle-income economy, high- income 220 
economy), residence status (yes, no), population of place of residence (urban, rural), ability 221 
to make ends meet with monthly income (very easily, easily, fairly easily, with some 222 
difficulty, with difficulty, with great difficulty), and health insurance (yes, no). This block was 223 
labelled Social Environment. Cox and Snell's R 2 and Nagelkerke's R 2 are reported as 224 
coefficients of determination. To check for violations of assumptions for logistic regression 225 
such as independence of errors, incomplete information from the predictors, diagnostics 226 
were conducted on all relevant variables. Collinearity diagnostics did not reveal significant 227 
multicollinearity concerns for any of the variables in the model. A p value of <.05 was 228 
considered to be statistically significant. SPSS 24.0 was used for all statistical analyses. 229 
 230 
Results 231 
Between May 1, 2020, and August 9, 2020, 7905 potential participants accessed the survey. 232 
597 participants did not give informed consent and thus were not able to access the survey. 233 
Another 593 participants gave informed consent but did not answer any further questions. 234 
From the remaining 6715 participants, 1223 individuals were excluded from the analyses 235 
because they did not respond to at least 50% of the survey. For the present analysis, 225 236 
participants from low-income and lower middle-income economies were not included. The 237 
final dataset consisted of 5267 participants. 238 
On average, the present sample is of early middle age (30.70 years ± 12.06), highly educated 239 
(60.7% tertiary education), mostly single (48.7%), and living in an urban environment 240 
(79.9%). 57.3% were assigned female at birth. 74.0% identified as binary [trans] man or 241 
[trans] woman, whereas 21.5% identified as a non-binary gender.  242 
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Basic and transgender-related demographics are presented in Table 1. Table 2 and Fig 1 243 
show the current country of residence of the participants.[14] Most participants lived in 244 
European countries. Fig 2 gives an overview of the physical health problems of the 245 
participants. 2768 (52.6%) reported a least one acute or chronic condition. 525 (10.0%) 246 
reported that these conditions resulted in severe limitations in daily activities, 1674 (31.8%) 247 
reported limitations to some extent. 509 (9.7%) had no limitations due to their chronic 248 
condition. 1009 (19.2%) of the participants were smokers. 327 (6.2%) used to smoke but had 249 
recently stopped. 3035 (73.6%) had at least once in their life seriously considered suicide, 250 
1827 (35.1%) had had suicidal thoughts since the beginning of the COVID-19 pandemic. 1797 251 
(34.5%) had had at least once suicide attempt, 168 (3.2%) have attempted suicide since the 252 
beginning of the COVID-19 pandemic.  253 
 254 
Table 1 Demographics and social situation 255 
 N (%) 
Total N° 5267 (100.00%) 
Age  
Years (Mean [SD]) 30.70 (12.06) 
Range 15.00 - 81.00 
  
Education  
No formal education 42 (0.8%) 
Primary education 354 (6.7%) 
Secondary education 1019 (19.3%) 
Tertiary education: vocational education and training 608 (11.5%) 
Tertiary education: college/university 2589 (49.2%) 
Other 302 (5.7%) 
I cannot or do not wish to answer the question 87 (1.7%) 
Missing  266 (5.1%) 
  
Relationship  
Single 2563 (48.7%) 
Married, living together 424 (8.1%) 
Married, but living separately 83 (1.6%) 
Registered relationship, living together 82 (1.6%) 
Registered relationship, but living separately 37 (0.7%) 
Non-registered relationship, living together 669 (12.7%) 
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Non-registered relationship, but living separately 675 (12.8%) 
In more than one relationship 199 (3.8%) 
Widowed 14 (0.3%) 
Other 198 (3.6%) 
I cannot or do not wish to answer the question 60 (1.1%) 





Student 1780 (33.8%) 
Vocational training 226 (4.3%) 
Unskilled worker 163 (3.1%) 
Employee 1635 (31.0%) 
Civil servant 185 (3.5%) 
Self-employed 447 (8.5%) 
Informal employment 119 (2.3%) 
Unemployed 812 (15.4%) 
Retired 112 (2.1%) 
Unable to work 422 (8.0%) 
Other 400 (7.6%) 





Person of color 528 (10.5%) 
Religious minority 908 (17.3%) 
Sexual minority 4414 (83.8%) 
Gender minority 4842 (91.9%) 
Minority due to disability status 1438 (27.3%) 
Another minority 1013 (19.3%) 
  
Gender  
(Trans) man 2141 (40.6%) 
(Trans) woman  1761 (33.4%) 




I don´t know, I don´t have a preference 144 (2.7%) 
Missing 44 (0.8%) 
  
Living according to gender  
Never 370 (7.0%) 
Occasionally 998 (18.9%) 
Almost always 1249 (23.7%) 
Always 2619 (49.7%) 
Missing 31 (0.6%) 
  
Sex assigned at birth  
Female 3018 (57.3%) 
Male 2194 (41.7%) 
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Missing 55 (1.0%) 
  
Place of residence  
City or the suburbs or outskirts of a city, or town 4210 (79.9%) 
A country village, farm, or home in the countryside 1043 (19.8%) 
Missing 14 (0.3%) 
  
Change of living situation due to COVID-19 591 (11.2%) 
Missing 10 (0.2%) 
  
Other people living in household 4102 (77.9%) 
Missing 0 (0.0%) 
  
Garden, balcony, other outdoor space 4088 (77.6%) 
Missing 20 (0.4%) 
  
Distress due to current living situation 2045 (38.8%) 
Missing 13 (0.2%) 
  
Making ends meet with the available monthly income  
Very easily 746 (14.2%) 
Easily 990 (18.8%) 
Fairly easily  1380 (26.2%) 
With some difficulty 1042 (19.8%) 
With difficulty 507 (9.6%) 
With great difficulty 390 (7.4%) 
I don´t want to say 78 (1.5%) 
I don´t know 121 (2.3%) 
Missing 13 (0.2%) 
  
a 
Multiple answers were possible 256 
 257 
Table 2 Countries  258 
Upper middle-income countries 762 (14.5%) 
Argentina 6 (0.1%) 
Armenia 34 (0.6%) 
Azerbaijan 19 (0.3%) 
Belarus 3 (0.1%) 
Bosnia and Herzegovina 3 (0.1%) 
Botswana 3 (0.1%) 
Brazil 36 (0.7%) 
Bulgaria 14 (0.3%) 
China 150 (2.7%) 
Georgia 27 (0.5%) 
Indonesia 2 (0.1%) 
Iran 1 (0.1%) 
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Iraq 1 (0.1%) 
Kazakhstan 30 (0.5%) 
Lebanon 6 (0.1%) 
Malaysia 2 (0.1%) 
Mexico 2 (0.1%) 
Montenegro 16 (0.3%) 
Namibia 4 (0.1%) 
North Macedonia 17 (0.3%) 
Russia 61 (1.1%) 
Serbia 69 (1.3%) 
South Africa 75 (1.4%) 
Turkey 181 (3.3%) 
  
High-income countries 4505 (85.5%) 
Australia 109 (2.0%) 
Austria 94 (1.7%) 
Barbados 1 (0.1%) 
Belgium 229 (4.2%) 
Canada 128 (2.3%) 
Chile 1 (0.1%) 
Croatia 30 (0.5%) 
Czech Republic 33 (0.6%) 
Denmark 17 (0.3%) 
Finland 62 (1.1%) 
France 66 (1.2%) 
Germany 1311 (23.9%) 
Greece 6 (0.1%) 
Hungary 74 (1.3%) 
Iceland 2 (0.1%) 
Ireland 8 (0.1%) 
Israel 4 (0.1%) 
Italy 48 (0.9%) 
Japan 3 (0.1%) 
Latvia 1 (0.1%) 
Liechtenstein 1 (0.1%) 
Luxembourg 2 (0.1%) 
Malta 7 (0.1%) 
Netherlands 175 (3.2%) 
New Zealand 37 (0.7%) 
Norway 33 (0.6%) 
Poland 296 (5.4%) 
Portugal 14 (0.3%) 
Republic of Korea 1 (0.1%) 
Romania 1 (0.1%) 
Seychelles 2 (0.1%) 
Slovakia 3 (0.1%) 
Slovenia 6 (0.1%) 
Spain 136 (2.5%) 
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Sweden 328 (6.0%) 
Switzerland 303 (5.5%) 
United Kingdom 563 (10.3%) 
United States 366 (6.7%) 
Taiwan 1 (0.1%) 
Missing 38 (0.7%) 
 259 
Fig 1 Participants current country of residence 260 
 261 
Fig 2 Acute and chronic conditions associated with a risk of a severe course of a COVID-19 262 
infection 263 
 264 
Table 3 gives an overview on COVID-19-related topics. Participants were quite satisfied with 265 
the information they received on the COVID-19 pandemic (M: 2.13 ± 0.8) and had high 266 
confidence in medical personnel to diagnose COVID-19 (M: 2.01 ± 0.8). Participants assumed 267 
it as not very likely to be diagnosed with COVID-19 (M: 2.90 ± 0.9) and as highly likely to 268 
survive a COVID-19 infection (M: 1.63 ± 0.8). They were concerned that members of their 269 
families or close friends will contract COVID-19 (M: 2.09 ± 0.9).  270 
 271 
Table 3 COVID-19 health care, avoidance, and knowledge  272 
  
COVID-19 health care  
Tested for COVID-19 within the last 14 days 130 (2.5%) 
In quarantine within the last 14 days 1481 (28.1%) 
Diagnosed with COVID-19 20 (0.4%) 
Recovered from COVID-19 14 (0.3%) 
Direct contact with a person diagnosed with COVID-19 109 (2.1%) 
Indirect contact with a person diagnosed with COVID-19 245 (4.7%) 
Contact with a person suspected to have COVID-19 818 (15.5%) 
  
COVID-19 health care avoidance  
Avoided COVID-19 testing because of fear of mistreatment 295 (5.6%) 
Avoided COVID-19 testing because of fear of discrimination 356 (6.8%) 
Will avoid COVID-19 testing because of fear of mistreatment 761 (14.4%) 
Will avoid COVID-19 testing because of fear of discrimination 888 (16.9%) 
  
COVID-19 knowledge  
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Transmission via droplet infection 5040 (95.7%) 
Increasing number of infections worldwide 5091 (96.7%) 
Increasing number of deaths worldwide 5067 (96.2%) 
Increasing number of survivals worldwide 4592 (87.2%) 
 273 
 274 
Table 4 summarises the influence of the COVID-19 pandemic on transgender health care. Of 275 
the 4699 participants that had undergone transition-related treatment or planned to do so, 276 
2875 (61.2%) feared access restrictions to transgender health care in the future due to the 277 
COVID-19 pandemic. Of the 3463 participants that had already undergone transition-related 278 
treatment, 1706 (49.3%) experienced restrictions in access to transgender health care 279 
services. A multivariate logistic regression analysis revealed that the sex assigned at birth 280 
and the adequacy of the monthly income predicted the experience of restrictions to 281 
transgender health care significantly. Participants assigned male at birth (OR: 2.239) and 282 
individuals with a lower income (OR: 1.102) were at greater risk of experiencing restrictions 283 
to transgender health care procedures (Table 5).  284 
 285 




Accessed at least one transgender health care procedure 3463 (65.7%) 
Experienced restrictions in access to transgender health care 1706 (49.3%) 
  
Accessed or planned at least one transgender-related treatment 
procedure 
4699 (89.2%) 
Fear restrictions to transgender health care in the future 2875 (61.2%) 
  
Access to hormones currently restricted 676 (21.8%) 
I cannot get a prescription 162 (24.0%) 
I cannot get an appointment with my hormone prescriber 249 (36.8%) 
A scheduled appointment was canceled without replacement 110 (16.3%) 
An appointment has been postponed 81 (12.0%) 
I am afraid to go to a medical provider or a hospital 189 (28.0%) 
My hormones cannot be supplied or can only be supplied at a 
lower dosage than has been prescribed to me 
177 (26.2%) 
Other 224 (33.1%) 
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Fear that access to hormones will be affected in the future 2316 (44.0%) 
  
Access to hair removal treatment currently restricted 665 (63.4%) 
  




Surgery cancelled or postponed  
Yes 454 (15.6%) 
Not yet, but I expect it will 568 (19.5%) 
  
Problems with aftercare for recent surgery 344 (56.4%) 
I cannot get an appointment for aftercare 45 (13.1%) 
A scheduled appointment was canceled without replacement 70 (20.3%) 
An appointment has been postponed 84 (24.4%) 
Complications (e.g., secondary bleeding) have not been treated 22 (6.4%) 
I am afraid to go to a doctor or a hospital 41 (11.9%) 
Other 82 (23.8%) 
  
Fear that surgical aftercare will be affected in the future 316 (21.9%) 
  
Access restricted to  
medical material necessary after surgery (e.g., vaginal dilators) 160 (3.0%) 
other material (e.g., binders, packing material) 651 (12.4%) 
non-medical supplies (e.g., wigs, make-up) 860 (16.3%) 
  
Access to counselling services (e.g., peer counselling) limited 2285 (43.4%) 
Alternative options for accessing counselling services 1271 (47.9%) 
  
Undergoing mental health care (e.g., for depression) 2055 (39.0%) 
Access to mental health care limited 1271 (61.9%) 
  




Member of a support group 1543 (28.5%) 
Access to support groups limited 1067 (69.2%) 
a 
Percentages refer to the number of participants who assessed a certain transgender health 287 
service, not to the total sample 288 
 289 
Table 5 Multiple regression analysis regarding the experience of restrictions to transgender 290 
health care 291 
 b ± SE CI p OR (95% CI) 
Demographics     
Age 0.000 ± 0.003 -0.007 - 0.006 0.899 1.000 (0.993, 1.006) 
Education -0.013 ± 0.067 -0.148 - 0.119 0.850 0.987 (0.869, 1.121) 
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Relationship 0.033 ± 0.079 -0.123 - 0.201 0.677 1.033 (0.886, 1.205) 
POC 0.158 ± 0.145 -0.129 - 0.436 0.269 1.171 (0.885, 1.550) 
Religious minority -0.083 ± 0.118 -0.320 - 0.144 0.466 0.920 (0.742, 1.142) 
Sexual minority 0.000 ± 0.116 -0.220 - 0.236 0.997 1.215 (0.891, 1.657) 
Gender minority 0.194 ± 0.157 -0.104 - 0.490 0.217 1.081 (0.891, 1.657) 
Disability 0.077 ± 0.095 -0.097 - 0.276 0.388 0.380 (0.903, 1.657) 
Sex assigned at birth 0.967 ± 0.082 0.809 -1.136 0.001 2.239 (2.239, 3.092) 
Non-binary gender -0.034 ± 0.119 -0.262 - 0.213 0.767 0.966 (0.769, 1.214) 
Social Environment     
Countries GNI per capita -0.167 ± 0.115 -0.392 - 0.056 0.153 0.846 (0.677, 1.057) 
Residence status -0.312 ± 0.254 -0.845 - 0.182 0.212 0.732 (0.449, 1.191) 
Population place of residence 0.106 ± 0.102 -0.092 - 0.320 0.292 1.111 (0.913, 1.354) 
Monthly income 0.097 ± 0.028 0.045 - 0.150 0.003 1.102 (1.043, 1.164) 
Health insurance  0.093 ± 0.175 -0.255 - 0.422 0.600 1.098 (0.792, 1.521) 
Constant 0.754 ± 0.554 -0.283 - 1.840 0.172 0.808 
R
2
 0.063 (Cox & Snell), 0.084 (Nagelkerke). Model χ2 (15) = 186.693, p=0.000 292 
 293 
Discussion 294 
As the first of its kind, the current study provides empirical insights into how the COVID-19 295 
pandemic affects the health care of transgender people in higher middle-income and high-296 
income countries. Over 50% of our participants had risk factors for a severe course of a 297 
COVID-19 infection and were at a high risk of avoiding testing or treatment of a potential 298 
COVID-19 infection due to fear of mistreatment and/or discrimination. Transgender health 299 
care was highly affected by the COVID-19 pandemic, with almost half of participants 300 
experiencing some sort of restricted access to health care. Restricted access to transgender 301 
health care applied rather universally to all transgender individuals, with a male sex assigned 302 
at birth and a lower monthly income as the only significant predictors. 303 
We found, that over 50% of transgender individuals have risk factors for a severe course of a 304 
COVID-19 infection (i.e., pre-existing medical conditions, being a smoker).[19-22] Compared 305 
with that, 23.5% of the working population in the EU and one-third of the European general 306 
population over 15 suffer from chronic conditions [23]. Similar numbers were found for 307 
other OECD countries [24]. Only in the US is the prevalence of chronic conditions between 308 
the transgender and the general population approximately equal, with 6 out of 10 adults 309 
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having a chronic condition [25]. Additionally, our participants were likely to avoid COVID-19 310 
testing or care because of fears of discrimination or mistreatment. This was true even 311 
though they were aware of the potential severity of COVID-19. This avoidance of care could 312 
even worsen their risk for serious consequences of COVID-19. 313 
We found that access to all transgender health care interventions was restricted due to the 314 
COVID-19 pandemic. This could be especially important for those who access ongoing 315 
treatments such as hormone therapy [3]. Hormone therapy is considered one of the most 316 
important treatment options for many transgender individuals and is highly associated with 317 
better mental health and quality of life [26]. An interruption of a hormone therapy is not 318 
associated with physical risks when gonadectomy was not performed. However, mental 319 
health risks must be considered. Stopping hormone treatment is often associated with a 320 
return of some features related to the sex assigned at birth (e.g., the return of 321 
menstruation). Moreover, mood swings and symptoms of depression and anxiety can occur  322 
[2, 3, 27]. There is a risk of psychological distress for the twenty percent of our sample 323 
whose hormones have been, or still are, restricted due to the pandemic. This association has 324 
also been reported by Wang and colleagues in their clinic in Beijing, China [11]. The same 325 
may well be true for hair removal treatments. While hair removal might not have the same 326 
value as hormone treatment, it is often performed as a supportive measure as hormone 327 
treatment alone could be insufficient to eliminate hair growth [27]. As a population, 328 
transgender individuals are already experiencing poor mental health, decreased quality of 329 
life, and are at high risk of discrimination and harassment [4, 8]; consequently, the 330 
restrictions in access to health care may affect transgender people to a greater extent than 331 
the general population. This higher vulnerability might also intersect with other minority 332 
statuses, such as being a person of colour.  333 
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All these transgender-specific issues caused by the COVID-19 pandemic need to be 334 
addressed by both structural changes as well as counselling services (e.g., peer counselling) 335 
and mental health care professionals. However, due to the COVID-19 pandemic, access to 336 
these measures is limited, too. For 43.4% of the participants who assessed counselling 337 
services, the access to those was restricted. 61.9% of those who undergo mental health care 338 
(e.g., for a pre-existing affective disorder) experienced access restrictions. Only half of the 339 
participants had alternative options for accessing counselling services (e.g., online 340 
consultations). Additionally, even access to low-threshold services, like support groups, was 341 
limited for two thirds of their members. In light of the available data, the COVID-19 342 
pandemic and its associated restrictions, combined with the systemic inequalities 343 
transgender people face in almost every country in the world, appears to have had a 344 
significant impact on the (mental) health of transgender people. Tragically, our study found 345 
that more than one third of our sample had had suicidal thoughts and 3.2% had attempted 346 
suicide since the beginning of the pandemic. And even though no causal conclusions can be 347 
drawn based on our cross-sectional study, it seems reasonable to assume that many of these 348 
suicidal attempts are linked to the situation caused by the COVID-19 pandemic. Indeed, at 349 
the least this association ought to be a warning sign that transgender people might be 350 
disproportionally affected by COVID-19. 351 
Some treatment options for transgender people such as genital surgeries [1] have been 352 
highly restricted due to the COVID-19 pandemic, too. At the time of the data analysis, 353 
approximately 15.6% of surgeries were already cancelled and another 19.5% of the 354 
participants expected their surgery to be cancelled. Additionally, aftercare for recent surgery 355 
was also restricted. As genital surgery is considered an important treatment option to 356 
increase quality of life and reduce psychological distress in transgender people [2, 28], a 357 
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postponement of these procedures can negatively impact a person’s well-being. Especially 358 
regarding surgical aftercare, restrictions could lead to serious health concerns like wound 359 
infections or disorders of wound healing [2]. Moreover, due to insecurities caused by the 360 
postponement of surgery, mental health problems could occur which should be addressed 361 
by counselling services or mental health professionals when possible. However, as the access 362 
to these services is restricted too, problems associated with postponed surgeries might not 363 
be addressed sufficiently and could intersect with already existing distress such as 364 
restrictions to accessing hormone treatment.  365 
All potential distress caused by restrictions to transgender health care might be further 366 
affected by social and socio-economic circumstances, as already reported by Perez-Brumer 367 
and Silva-Santisteban [12]. We found that one third of our participants had difficulties 368 
making ends meet with their available monthly income and another third experienced 369 
distress due to their current living situation. However, using regression analysis, we only 370 
found a male sex assigned at birth and a lower monthly income to be significant predictors 371 
for the experience of restrictions to transgender health care. The significant association to a 372 
male sex assigned at birth could be due to a greater stigma towards transgender people 373 
assigned male at birth [29]. The association between the monthly income and a higher risk 374 
of restrictions to transgender health care with an OR of 1.102 could be considered weak. 375 
Therefore, it seems that the COVID-19 pandemic hits the transgender population in higher-376 
middle-income and high-income countries in its entirety and that there aren´t any major 377 
protective social factors.  378 
The strength of our study is that it includes a high number of participants from several 379 
countries all over the world. This is important as, with a number of 6.8 to 355 per 100,000, 380 
transgender people are only a small group within the general population [30]. The results 381 
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are therefore likely to be applicable to other upper middle-income and high-income 382 
countries with similar health systems. Moreover, the study was developed and conducted by 383 
transgender researchers in close cooperation with community organisations. Therefore, we 384 
intentionally took power differences between researchers and study subjects into account 385 
and tried to ensure tangible outcomes for the community. 386 
We consider the type of data collection a potential limitation of our study due to access to 387 
the internet being a necessity. This could have excluded participants with low income or 388 
without experience with digital technology. However, our sample was comparable to 389 
previous studies, in terms of gender or education, for example [7, 18].  As there is still a 390 
dynamic COVID-19 situation, with increasing and decreasing numbers of infections and 391 
changing national measures to address these, this research also did not explore international 392 
comparisons. In countries where COVID-19 has been more effectively suppressed the 393 
impacts of COVID-19 could, therefore, be lower. Moreover, we only analysed data from 394 
higher middle-income and high-income countries, which is why the results cannot be 395 
generalized to countries with lower GNI per capita. However, as participant recruitment in 396 
lower middle-income countries and low-income countries appeared to be difficult (but is still 397 
ongoing) the clear need for evidence of how COVID-19 affects transgender people led us to 398 
focus on the present data. We currently strive to provide data from lower middle-income 399 
countries and low-income countries as soon as possible. 400 
In sum, it appears that the COVID-19 pandemic has an extraordinary impact on the 401 
transgender population in higher middle-income and high-income countries, and that 402 
transgender people might suffer under the severity of the pandemic even more than the 403 
general population. This is due to the intersections between their status as a vulnerable 404 
social group, their high amount of medical risk factors, and their need for ongoing medical 405 
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treatment. The COVID-19 pandemic can potentiate these vulnerabilities, add new challenges 406 
for transgender people, and can therefore lead to devastating consequences such as severe 407 
physical or mental health issues, self-harming behaviour, and even suicidality. 408 
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Fig 1 Participants current country of residence
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Fig 2 Acute and chronic conditions associated with a risk of a 
severe course of a COVID-19 infection
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